Pomalidomide 4'-PEG5-acid
Modify Date: 2024-01-18 16:49:55
Pomalidomide 4'-PEG5-acid structure
|
Common Name | Pomalidomide 4'-PEG5-acid | ||
|---|---|---|---|---|
| CAS Number | 2139348-63-1 | Molecular Weight | 565.57 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C26H35N3O11 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Pomalidomide 4'-PEG5-acidPomalidomide 4'-PEG5-acid (Pomalidomide-PEG5-CO2H) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 5-unit PEG linker used in PROTAC technology[1]. |
| Name | Pomalidomide 4'-PEG5-acid |
|---|
| Description | Pomalidomide 4'-PEG5-acid (Pomalidomide-PEG5-CO2H) is a synthesized E3 ligase ligand-linker conjugate that incorporates the Pomalidomide based cereblon ligand and 5-unit PEG linker used in PROTAC technology[1]. |
|---|---|
| Related Catalog | |
| Target |
Cereblon |
| In Vitro | PROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins[1]. |
| References |
| Molecular Formula | C26H35N3O11 |
|---|---|
| Molecular Weight | 565.57 |
| Storage condition | -20°C |